Medtronic Plc (MDT), a leading medical device company, displays positive growth through a series of significant events. Besides, robust performance in Q4
financial results has helped the firm finish the fiscal year strong.
Jim Cramer, an experienced stock market commentator, endorsed MDT, noting it as a powerhouse in the medical device segment. The company plans to
spin-off its Diabetes Division as a separate publicly-traded entity in the next 18 months. Furthermore, there is strong investor interest in MDT stocks due to consecutive upticks in shares and promising third-quarter
earnings. Unfortunately, despite these promising trends, the stock occasionally encountered dips when compared to market improvements. Medtronic also remains committed to returning capital to shareholders, announcing a
dividend increase. Equally important is how Medtronic's
CEO Geoff Martha will articulate their growth strategy at the Bernstein's Strategic Decisions Conference. On a downside, recalling of a product led to a slight slump of MDT shares. Yet, the company's standing remains attractive for dividend seekers and seen as one of the best high-yield dividend stocks for 2025.
Medtronic Plc MDT News Analytics from Tue, 05 Nov 2024 08:00:00 GMT to Fri, 06 Jun 2025 19:39:07 GMT -
Rating 6
- Innovation 2
- Information 8
- Rumor -2
